Home › Therapeutic areas › Neurology › Alzheimer's Disease
Alzheimer's Disease (6 companies)
Companies with an active program in Alzheimer's Disease.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| ABOS | Acumen Pharmaceuticals | Neurology | 2 | Phase 2 | 2 |
| CGTX | COGNITION THERAPEUTICS INC | NeurologyOphthalmology | 1 | Phase 2 | 2 |
| GANX | Gain Therapeutics, Inc. | MetabolicNeurology Rare | 1 | Phase 1 | 5 |
| LXEO | Lexeo Therapeutics, Inc. | CardiovascularNeurology Rare | 3 | Phase 1 | 10 |
| LGVN | Longeveron Inc. | CardiovascularMetabolicNeurology Rare | 1 | Phase 2 | 4 |
| VYGR | Voyager Therapeutics, Inc. | MetabolicNeurology Rare | 2 | Phase 1 | 7 |
No companies match.